OR WAIT null SECS
Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.
August 02, 2017
Media manufacturers are focused on reducing risk, improving quality and consistency, and managing costs.
July 05, 2017
Cannabinoids have potential to treat a variety of diseases, but pharmaceutical companies must first develop cost-effective ways to access pharmaceutically pure materials without marijuana cultivation.
July 02, 2017
Polymers and surfactants impact stability and long-term performance.
June 08, 2017
Advances in chemical synthesis are enabling greener, more cost-efficient processes for API manufacturing.
June 02, 2017
Efficient synthesis of complex cannabinoids is possible while avoiding marijuana cultivation.
May 15, 2017
The decision to use disposable bioreactors is now driven by commercial rather than technological considerations.